Journal
FEBS LETTERS
Volume 595, Issue 1, Pages 58-67Publisher
WILEY
DOI: 10.1002/1873-3468.13963
Keywords
bone loss; DRP1; NFATc1; osteoclastogenesis; RANKL
Funding
- LG Yonam Foundation (of Korea)
- National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2019R1A2C1008191]
Ask authors/readers for more resources
The mitochondrial protein DRP1 plays a role in osteoclast differentiation by regulating the c-Fos-NFATc1 axis, highlighting its importance in osteoclastogenesis.
Dynamin-related protein 1 (DRP1) is a mitochondrial membrane GTPase and regulates mitochondrial fission. In this study, we found that the cytokine RANKL increased the expression of DRP1 and its receptor proteins, Fis1, Mid49, and Mid 51, during osteoclast formation in mouse bone marrow-derived macrophages. Inactivation of the kinase GSK3 beta appeared to induce DRP1 expression. DRP1 knockdown or the DRP1 inhibitor Mdivi1 suppressed osteoclast differentiation via downregulation of c-Fos and NFATc1, the key transcription factor for osteoclast formation. Finally, the DRP1 inhibitor suppressed lipopolysaccharide-induced osteoclast formation in a calvarial model and ovariectomy-induced bone loss in vivo. Taken together, our data demonstrate that DRP1 positively contributes to RANKL-induced osteoclast differentiation by regulating the c-Fos-NFATc1 axis, suggesting the importance of mitochondrial DRP1 in osteoclastogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available